16^th World Congress on Endocrinology & Diabetes September 08-09, 2020 Prague, Czech Republic

Eduardo J. Simoes MD, MSc, MPH completed his medical degree from Faculdade de Medicina, Universidade de Pernambuco (Brazil) in 1981, Master of Science in Community Health and Diploma of Hygiene and Tropical Medicine from the London School of Hygiene and Tropical Medicine, University of London (England) in 1987, and Master of Public Health from Emory School of Public Health, Emory University (United States) in 1991. He is the chair, Dr. Stuart Wesbury distinguished professor and HMI Alumni distinguished professor of the Department of Health Management and Informatics of the University Of Missouri School Of Medicine (since September 27, 2011). He served as primarycare physician, health district planner, and director of three Primary Healthcare Clinics in the City of Recife Secretariat of Health (1980-1989). He was a visiting associate with the Centers for Diseases Control and Prevention (1991-1993), associate researcher of Emory University School of Medicine (1994), medical and state epidemiologist with the Missouri Department of Health (1995-2003). He was director of the Prevention Research Centers Program Office of the Centers for Disease Control and Prevention (February 2003- September 2011), assistant and adjunct professor of Saint Louis University School of Public Health (1995-2011). His research work includes etiological studies, public health practice research, and evaluation of population-based interventions. His public health work includes development of disease prevention and health promotion programs, surveillance systems and evaluation of public health interventions. Dr. Simoes has 136 publications in peer-reviewed journals, 13 book chapters and over 150 presentations in national and international conferences. He is a fellow of the American College of Epidemiology, member of the Society for Epidemiological Research and American College of Healthcare Executives. He serves as an editorial board member of scientific journals of repute and consultant of many international and national health organizations.

Health Management and Informatics, Epidemiology, Disease Control and Prevention, public health practice research, etiological studies and evaluation of population-based interventions

Francesco Lippi is Graduated in Medicine and Surgery at the University of Pisa, Albo Pisa 1879/79. Specialization in Endocrinology at the University of Pisa July 1982. Specialization in Nuclear Medicine at the University of Florence July 1987. He has taught at the Institute of Clinical Methodology and the Institute of Endocrinology of the University of Pisa. From 1990 as a Professor of Endocrinology at the University Hospital of Pisa. He conducted the study (pahe se III) on effects of recombinant human TSH (rhTSH) adjuvant therapy in compassionate use program for patients with differentiated thyroid carcinoma. Then used a low activiy of radiodine therapy for treatment of thyroid remnants after surgery using rhTSH therapy without widrawall l-tiroxine. After Chernobyl accident partecipate to European Commision Study for diagnosis and tratment of children exposed to the radiations or radioactive follow-out (1990-1995). He held master's and refresher courses in Endocrinology and Nuclear Medicine at Stanford University (USA) for the treatment of thyroid carcinoma with rhTSH. He held an update master's degree at the Mayo Clinic in Rochester (USA). Associate of scientific associations in the field of Endocrinology as Endocrine Society, American Thyroid Association, European Thyroid Association and Medical Endocrinolist Association (AME).

Endocrinology, Nuclear Medicine, thyroid carcinoma

Medical doctor obtained his PhD from Catholic University of Louvain / Brussels/ Belgium in 1986. Worked as researcher and university professor for about 17 years in Rudolf Magnus Institute for Neurosciences in Medical college of University of Utrecht/ Holland. Head of department of Physiology in the Arabian Gulf University for 6 years. Author of more than 60 scientific original papers

Diabetes Mellitus, Neurosciences and Physiology

Irina Gette has completed her PhD at the age of 35 years from Ural State Medical Academy. She is senior researcher in the Ural Federal University, and senior researcher in the Institute of Immunology and Physiology. She has published more than 50 papers in reputed journals.

Type 1 and type 2 diabetes mellitus, Immunology and Physiology.

Vladimír Štrbák has worked at Institute of Experimental Endocrinology, Slovak Academy of Sciences. He was Organizer and chairman of the five International symposia on Hormones in Milk, resident of the International Symposium on Cell volume and function 1997. He was Organizer and chairman Symposium Cell Volume, physiological and pathophysiological aspects, 5th International Congress of Pathophysiology, June 28-July 1, 2006,Beijing, China, published in Chinese Journal of Pathophysiology, June 2006, Volume 22, No 13, Supplement p. 167. Organizer and chairman of the session Cell Volume Regulation and Cell Functions The Physiology of Anion Transport and Cell Volume Regulation (August 3-6, 2009, Okazaki, Japan) Symposium following the IUPS Congres (Kyoto). Most important activities in last three years: 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, Dubai, UAE, Organizing Committee Member, Keynote speaker. 13th Global Diabetes Conference and Medicare Expo, August 8-10, 2016, Birmingham, UK, Organizing Committee Member, Keynote speaker. 16th Global Diabetes Conference and Medicare Expo, March 22-23,2017 Rome, Italy, Organizing Committee Member, Keynote speaker, Chair of the Session. 15th World Congress on Endocrinology and Diabetes, September 20-21, 2019, Prague, Czech Republic, Organizing Committee member, Keynote speaker, Chair of the Session.

Endocrinology, Diabetes and Pathophysiology

Ravi Muppirala is a Biophysicst who has held academic appointments at T.I.F.R., Carnegie-Mellon, Syracuse University and University of Michigan. His expertise and interests span NMR, bio-molecular structure-dynamics, origins of primitive cells and type-2 diabetes. His current research interests include targeting the root-causes of type2 and new therapeutics towards pulsatile endogenous insulin secretion.

Type-2 diabetes, NMR, bio-molecular structure-dynamics and pulsatile endogenous insulin secretion